Nasdaq
GENB
Generate Biomedicines, Inc.
- Health Care
- Listed 2026
- 1 day
- −4.1%
- 1 month
- −14.4%
- 1 year
- —
$13.89 · Mkt cap $1.78B
At the 6 Aug 2026 close
Nasdaq
Generate Biomedicines, Inc.
$13.89 · Mkt cap $1.78B
At the 6 Aug 2026 close
Generate Biomedicines, Inc. trades under the ticker GENB on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2026. Its market capitalisation is $1.78B. The last closing price was $13.89, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing.
This page exists because GENB is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.